Target Organs DamagePreVENT-A GPNCT01055353

Evaluation of Target Organs Damage in Hypertensive Patients

An observational study of Target Organs Damage and Hypertensive, run by AstraZeneca at 905 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Target Organs Damage, Hypertensive, no Known Cardiovascular
How many people: 1,857 participants
Where: 905 sitesFrance
Study dates: Jan 2010to Jun 2010
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Study population: First 2 consecutive adults with hypertension, with no known cardiovascular (CV) or renal disease, seen by general practitioner

Who may be able to join

diagnosis of essential hypertension (treated or untreated); HT not discovered on the day of the consultation; no documented clinical cardiovascular or renal disease.

Who cannot join

Trial locations and contacts

905 sites in 1 country.

City, postcode or hospital

300 sites in 1 country

France300 sites

Research Site
Abbaretz
Research Site
Achenheim
Research Site
Achères
Research Site
Achicourt
Research Site
Agde
Research Site
Aigurande
Research Site
Aix-en-Provence
Research Site
Aix-les-Bains
Research Site
Ajaccio
Research Site
Albertville
Research Site
Albi
Research Site
Alès
Research Site
Allaire
Research Site
Alligny-Cosne
Research Site
Allouagne
Research Site
Ambrières-les-Vallées
Research Site
Amiens
Research Site
Amphion-les-Bains
Research Site
Amplepuis
Research Site
Andance
Research Site
Andeville
Research Site
Annecy
Research Site
Annecy-le-Vieux
Research Site
Annonay
Research Site
Antibes
Research Site
Antony
Research Site
Arbois
Research Site
Arc-et-Senans
Research Site
Arcachon
Research Site
Arches
Research Site
Argenteuil
Research Site
Arles
Research Site
Arras
Research Site
Ars
Research Site
Art-sur-Meurthe
Research Site
Artannes-sur-Indre
Research Site
Arudy
Research Site
Asnières-sur-Seine
Research Site
Athies
Research Site
Aubagne
Research Site
Aubervilliers
Research Site
Aubière
Research Site
Auby
Research Site
Auch
Research Site
Auchel
Research Site
Auchy-les-Mines
Research Site
Audincourt
Research Site
Aulnay-sous-Bois
Research Site
Aumale
Research Site
Aumont-Aubrac
Research Site
Autun
Research Site
Auxerre
Research Site
Avesnes-le-Sec
Research Site
Avignon
Research Site
Avoine
Research Site
Avrillé
Research Site
Badonviller
Research Site
Bâgé-le-Châtel
Research Site
Bagnères-de-Bigorre
Research Site
Bagneux
Research Site
Bagnols-sur-Cèze
Research Site
Baignes Ste Radegonde
Research Site
Baisieux
Research Site
Balaruc-les-Bains
Research Site
Banyuls de la Marenda
Research Site
Barberaz
Research Site
Barbezieux-Saint-Hilaire
Research Site
Bassussarry
Research Site
Bayonne
Research Site
Beaulieu
Research Site
Beaumesnil
Research Site
Beaumont
Research Site
Beaumont-en-Véron
Research Site
Beaumont-sur-Lèze
Research Site
Beautor
Research Site
Beauvais
Research Site
Bélâbre
Research Site
Belleville-sur-Meuse
Research Site
Benfeld
Research Site
Benquet
Research Site
Bérat
Research Site
Bergerac
Research Site
Bergholtz
Research Site
Bersée
Research Site
Bertrichamps
Research Site
Bessines
Research Site
Bétaille
Research Site
Béville-le-Comte
Research Site
Beynes
Research Site
Béziers
Research Site
Biarritz
Research Site
Biganos
Research Site
Blangy-sur-Bresle
Research Site
Blanquefort
Research Site
Bohars
Research Site
Bois-Colombes
Research Site
Boisset
Research Site
Bondues
Research Site
Bondy
Research Site
Bordeaux
Research Site
Bort-les-Orgues
Research Site
Bouc-Bel-Air
Research Site
Boujan-sur-Libron
Research Site
Boulogne-Billancourt
Research Site
Bourbriac
Research Site
Bourg-Achard
Research Site
Bourg-Argental
Research Site
Bourg-la-Reine
Research Site
Bourg-lès-Valence
Research Site
Bourges
Research Site
Bousbecque
Research Site
Boussay
Research Site
Bousse
Research Site
Bozel
Research Site
Braine
Research Site
Brest
Research Site
Breteuil
Research Site
Bretignolles-sur-Mer
Research Site
Breuil-le-Sec
Research Site
Brignais
Research Site
Brignoud
Research Site
Briollay
Research Site
Brion-près-Thouet
Research Site
Broût-Vernet
Research Site
Bruère-Allichamps
Research Site
Bubry
Research Site
Bulgnéville
Research Site
Bulles
Research Site
Cabanac-et-Villagrains
Research Site
Callac de Bretagne
Research Site
Caluire-et-Cuire
Research Site
Camblanes
Research Site
Cambrai
Research Site
Camors
Research Site
Campbon
Research Site
Canéjan
Research Site
Canet-Plage
Research Site
Cannes
Research Site
Cany-Barville
Research Site
Capbreton
Research Site
Capdenac-Gare
Research Site
Cappelle-en-Pévèle
Research Site
Carantec
Research Site
Carbon-Blanc
Research Site
Carcassonne
Research Site
Carentan
Research Site
Carnon-Plage
Research Site
Carpentras
Research Site
Carpiquet
Research Site
Carresse-Cassaber
Research Site
Carrières-sur-Seine
Research Site
Carros
Research Site
Cavaillon
Research Site
Celles-sur-Plaine
Research Site
Cénac
Research Site
Cérilly
Research Site
Cerizay
Research Site
Châbons
Research Site
Chaleins
Research Site
Chamalières
Research Site
Chambéry
Research Site
Chambray-lès-Tours
Research Site
Chamonix
Research Site
Champagnole
Research Site
Champcueil
Research Site
Champigneulles
Research Site
Champigny-sur-Marne
Research Site
Chanac
Research Site
Chantilly
Research Site
Chantonnay
Research Site
Charleville-Mézières
Research Site
Charmes
Research Site
Charmoy
Research Site
Chasseneuil-du-Poitou
Research Site
Château-Chinon(Ville)
Research Site
Château-Thierry
Research Site
Châteaubriant
Research Site
Châteauneuf-en-Thymerais
Research Site
Châteauneuf-sur-Cher
Research Site
Châtellerault
Research Site
Châtenay-Malabry
Research Site
Châtillon-Coligny
Research Site
Châtillon-sur-Colmont
Research Site
Chauvigny
Research Site
Cherbourg Octeville
Research Site
Cherves-Richemont
Research Site
Chinon
Research Site
Ciboure
Research Site
Cinq-Mars-la-Pile
Research Site
Ciry-le-Noble
Research Site
Clairac
Research Site
Clary
Research Site
Clermont-Ferrand
Research Site
Clichy
Research Site
Clichy-sous-Bois
Research Site
Cluny
Research Site
Cognac
Research Site
Collioure
Research Site
Colomars
Research Site
Colombes
Research Site
Colomiers
Research Site
Combrit
Research Site
Commentry
Research Site
Conches-en-Ouche
Research Site
Condrieu
Research Site
Connaux
Research Site
Corbehem
Research Site
Corbeil-Essonnes
Research Site
Corcieux
Research Site
Corseul
Research Site
Coudekerque-Branche
Research Site
Couhé
Research Site
Courbevoie
Research Site
Courcy
Research Site
Cournon-d'Auvergne
Research Site
Courpière
Research Site
Courrières
Research Site
Coursan
Research Site
Courthézon
Research Site
Coutances
Research Site
Coutouvre
Research Site
Coye-la-Forêt
Research Site
Cran-Gevrier
Research Site
Crécy-sur-Serre
Research Site
Creil
Research Site
Créteil
Research Site
Crévic
Research Site
Criquetot-l'Esneval
Research Site
Croissy-sur-Seine
Research Site
Croix
Research Site
Cubjac
Research Site
Cugand
Research Site
Cunlhat
Research Site
Dainville
Research Site
Dambach-la-Ville
Research Site
Deauville
Research Site
Dieppe
Research Site
Dieulouard
Research Site
Dieuze
Research Site
Dijon
Research Site
Dinard
Research Site
Dinsheim-sur-Bruche
Research Site
Dole
Research Site
Domfront
Research Site
Dornes
Research Site
Draguignan
Research Site
Drancy
Research Site
Échenoz-la-Méline
Research Site
Échirolles
Research Site
Elna
Research Site
Enghien-les-Bains
Research Site
Entraygues-sur-Truyère
Research Site
Épernon
Research Site
Épierre
Research Site
Épinal
Research Site
Épinay-sur-Seine
Research Site
Épron
Research Site
Eragny Sur Oise
Research Site
Ermont
Research Site
Escaudain
Research Site
Esquerdes
Research Site
Estaing
Research Site
Étalondes
Research Site
Étretat
Research Site
Étupes
Research Site
Évin-Malmaison
Research Site
Évron
Research Site
Eyguières
Research Site
Ézy-sur-Eure
Research Site
Fabrezan
Research Site
Faches-Thumesnil
Research Site
Fameck
Research Site
Faverges
Research Site
Fécamp
Research Site
Fegersheim
Research Site
Félines
Research Site
Felletin
Research Site
Fère-en-Tardenois
Research Site
Firmi
Research Site
Firminy
Research Site
Fitilieu
Research Site
Fitz-James
Research Site
Flers
Research Site
Fleurance
Research Site
Florensac
Research Site
Folembray
Research Site
Fontaine-lès-Dijon
Research Site
Fontès
Research Site
Fos-sur-Mer
Research Site
Fosses
Research Site
Fouras
Research Site
Fourneaux
Research Site
Franconville
Research Site
Frasne
Research Site
Fréjus
Research Site
Fresnes-sur-Escaut
Research Site
Froberville
Research Site
Fromentine
Research Site
Frontenex
Research Site
Frotey-lès-Vesoul

Other trials in France

About this study

Official title: Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control

Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control

Conditions: Target Organs Damage, Hypertensive, no Known Cardiovascular, no Known Renal Disease
Keywords: Target organs damage, hypertensive patients

What is being measured

The primary outcome is the main question the study is designed to answer.

To evaluate the frequency of evaluation of preclinical target organs damage in hypertensive patients with no known cardiovascular or renal disease, by taking blood pressure (controlled or uncontrolled HT*) into account
Measured: once / 1 Year

Secondary outcomes (3)

To describe the patient profile (socio-demographic, risk factors, comorbidities, global CV risk level estimated by the doctor and calculated retrospectively [according to ESH 2007]) associated with screening for target organs damage
To describe the modalities of patient follow-up and management
To compare the frequency of evaluation of target organs damage as a function of the modalities of management of CV risk factors at the time of the consultation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Jan 2010Jun 2010

First posted25 Jan 2010 (estimated)
Study startJan 2010
Primary completionJun 2010
Study completionJun 2010

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Target Organs DamageStudies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Cohort
Time perspective: Cross-sectional
Enrolment: 1,857 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT01055353
Sponsor's protocol ID: NIS-CFR-DUM-2009/2
Acronym: PreVENT-A GP
Status last verified: May 2011
First submitted: 21 Jan 2010
Last updated: 12 May 2011
Results posted: No
Data monitoring committee: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingObservational study
Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Malignant Hypertension
RecruitingObservational study
Predictors of In-Hospital Mortality in Severe Abdominal Trauma
Abdominal Injuries, Wounds and Injuries
Not yet recruitingObservational study
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension
Hypertension, Hypertension (HTN)
RecruitingObservational study
GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry
Hypertension, Target Organ Damage
Enrolling by invitationObservational study
Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension
Coarctation of the Aorta

All Target Organs Damage trials

Study at a glance

From the registry record, last updated by the sponsor on 12 May 2011. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control
ClinicalTrials.gov ID: NCT01055353
Acronym / sponsor ID: PreVENT-A GP / NIS-CFR-DUM-2009/2
Conditions: Target Organs Damage, Hypertensive, no Known Cardiovascular, no Known Renal Disease
Keywords: Target organs damage, hypertensive patients
Study type: Observational
Recruitment status: Completed
Enrolment: 1,857 participants (actual)
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: Jan 2010
Primary completion: Jun 2010 (actual)
Study completion: Jun 2010 (actual)
First posted: 25 Jan 2010 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control

Study design

Observational model: Cohort
Time perspective: Cross-sectional

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: First 2 consecutive adults with hypertension, with no known cardiovascular (CV) or renal disease, seen by general practitioner

Key inclusion criteria (1 listed)

diagnosis of essential hypertension (treated or untreated); HT not discovered on the day of the consultation; no documented clinical cardiovascular or renal disease.

Key exclusion criteria (1 listed)

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

To evaluate the frequency of evaluation of preclinical target organs damage in hypertensive patients with no known cardiovascular or renal disease, by taking blood pressure (controlled or uncontrolled HT*) into account
Time frame: once / 1 Year

3 secondary outcomes

To describe the patient profile (socio-demographic, risk factors, comorbidities, global CV risk level estimated by the doctor and calculated retrospectively [according to ESH 2007]) associated with screening for target organs damage
To describe the modalities of patient follow-up and management
To compare the frequency of evaluation of target organs damage as a function of the modalities of management of CV risk factors at the time of the consultation.

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2011.

Related trials for Target Organs Damage

RecruitingObservational study
Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Malignant Hypertension
RecruitingObservational study
Predictors of In-Hospital Mortality in Severe Abdominal Trauma
Abdominal Injuries, Wounds and Injuries
Not yet recruitingObservational study
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension
Hypertension, Hypertension (HTN)
RecruitingObservational study
GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry
Hypertension, Target Organ Damage
Enrolling by invitationObservational study
Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension
Coarctation of the Aorta

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Pascal Piedbois study director

AstraZeneca

905 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Target Organs Damage and Hypertensive, run by AstraZeneca at 905 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 905 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To evaluate the frequency of evaluation of preclinical target organs damage in hypertensive patients with no known cardiovascular or renal disease, by taking blood pressure (controlled or uncontrolled HT*) into account (time frame: once / 1 Year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01055353.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2011.